Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Radiation Oncology

Background:

• Radiotherapy is a cornerstone of cancer treatment.
• Radiation-induced damage to normal tissues remains a significant challenge.
• Cerium oxide nanoparticles (nanoceria) have demonstrated antioxidant and radioprotective properties.

Purpose of the Study:

• To evaluate the radioprotective potential of engineered nanoceria in human normal and tumor cells.
• To determine the selectivity of nanoceria's radioprotection towards normal versus cancerous cells.

Main Methods:

• Human normal and tumor cell lines were treated with nanoceria.
• Cells were subsequently exposed to ionizing radiation.
• Cell survival rates were quantified to assess radioprotection.

Main Results:

• Nanoceria treatment conferred approximately 99% protection to normal human cells against radiation-induced death.
• The same concentration of nanoceria provided negligible protection to human breast tumor cells (MCF-7).
• This study is the first to demonstrate selective radioprotection by nanoceria in normal human breast cells compared to breast tumor cells.

Conclusions:

• Engineered nanoceria exhibit selective radioprotective effects, shielding normal cells while sparing tumor cells.
• Nanoceria hold promise as a therapeutic agent to mitigate radiation toxicity in cancer patients.
• Further research is warranted to explore the mechanisms underlying nanoceria's selective radioprotection.